TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
ADDvance Pharma in Scandinavia AB
Closing information (x1000 DKK)
| Closing information | 2024/08 | 2023/08 | 2022/08 |
| Turnover |
12,702
|
9,461 | |
| Financial expenses |
0
|
60 | |
| Earnings before taxes |
2,630
|
1,042 | |
| EBITDA |
2,526
|
1,102 | |
| Total assets |
7,230
|
5,646 | |
| Current assets |
5,815
|
5,149 | |
| Current liabilities |
3,294
|
1,936 | |
| Equity capital |
3,616
|
3,362 | |
| - share capital |
63
|
70 | |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Solvency |
50.0%
|
59.5% | |
| Turnover per employee |
6,351
|
4,730 | |
| Profit as a percentage of turnover |
20.7%
|
11.0% | |
| Return on assets (ROA) |
36.4%
|
19.5% | |
| Current ratio |
176.5%
|
266.0% | |
| Return on equity (ROE) |
72.7%
|
31.0% | |
| Change turnover |
4,151
|
282 | |
| Change turnover % |
3%
|
49%
|
3% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.